Literature DB >> 19219535

Association of genetic variants in Methylenetetrahydrofolate Reductase and Paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease.

Makbule Aydin1, Cahide Gokkusu, Elif Ozkok, Feti Tulubas, Yesim Unlucerci, Burak Pamukcu, Zeynep Ozbek, Berrin Umman.   

Abstract

BACKGROUND: The aim of the present study was to investigate the association between genetic variants in metylenetetrahydrofolate reductase (MTHFR) and Paraoxonase-1 (PON1) 55/192 genes and total homocysteine (tHcy), folate, B12 vitamin, and PON1 levels in patients with coronary artery disease (CAD).
METHODS: The study included 235 patients with CAD and 268 healthy control subjects.
RESULTS: LL and LM genotypes and L allele of PON1 55 were over-represented in patients. In contrast, MM genotype and M allele were more frequent in controls. QQ genotype and Q allele of PON1 192 and CT genotype of MTHFR were significantly diminished and QR genotype and R allele were significantly elevated in CAD patients compared with controls. The plasma tHcy were elevated but B12 levels were diminished in patients. PON1 55 and 192 genetic variants were significantly associated with PON1 activity, triglyceride, total cholesterol, tHcy and, high-density lipoprotein-cholesterol and low-density lipoprotein-cholesterol in patients, respectively.
CONCLUSION: Genetic variants of PON1 55/192 and MTHFR were associated with CAD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219535     DOI: 10.1007/s11010-009-0038-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  63 in total

1.  C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.

Authors:  N Q Hanson; O Aras ; F Yang; M Y Tsai
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

2.  Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.

Authors:  J Selhub; P F Jacques; A G Bostom; P W Wilson; I H Rosenberg
Journal:  Public Health Rev       Date:  2000

3.  Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

Authors:  D K Sanghera; N Saha; C E Aston; M I Kamboh
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

4.  Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease.

Authors:  David J Stott; Graham MacIntosh; Gordon D O Lowe; Ann Rumley; Alex D McMahon; Peter Langhorne; R Campbell Tait; Denis St J O'Reilly; Edward G Spilg; Jonathan B MacDonald; Peter W MacFarlane; Rudi G J Westendorp
Journal:  Am J Clin Nutr       Date:  2005-12       Impact factor: 7.045

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database.

Authors:  Benjamin A Steinberg; Christopher P Cannon; Adrian F Hernandez; Wenqin Pan; Eric D Peterson; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2007-08-13       Impact factor: 2.778

7.  Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.

Authors:  Elif Ozkök; Makbule Aydin; Erhan Babalik; Zeynep Ozbek; Nurhan Ince; Ihsan Kara
Journal:  Med Sci Monit       Date:  2008-10

8.  The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.

Authors:  D Ombres; G Pannitteri; A Montali; A Candeloro; F Seccareccia; F Campagna; R Cantini; P P Campa; G Ricci; M Arca
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

9.  Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk.

Authors:  Ihsan Kara; Ali Sazci; Emel Ergul; Guner Kaya; Gamze Kilic
Journal:  Brain Res Mol Brain Res       Date:  2003-03-17

10.  Homocysteine and stroke: evidence on a causal link from mendelian randomisation.

Authors:  Juan P Casas; Leonelo E Bautista; Liam Smeeth; Pankaj Sharma; Aroon D Hingorani
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

View more
  9 in total

1.  The association between GSTT1, M1, and P1 polymorphisms with coronary artery disease in Western Iran.

Authors:  Hamid Nomani; Hadi Mozafari; Shahrokh Mohamadzadeh Ghobadloo; Zohreh Rahimi; Asad Vaisi Raygani; Mehr Ali Rahimi; Asghar Fadaei Haghi; Ali Asghar Keshavarz
Journal:  Mol Cell Biochem       Date:  2011-04-16       Impact factor: 3.396

2.  Synergism between paraoxonase Arg 192 and the angiotensin converting enzyme D allele is associated with severity of coronary artery disease.

Authors:  Asad Vaisi-Raygani; Zohreh Rahimi; Haidar Tavilani; Hadiss Vaisi-Raygani; A Kiani; M Aminian; E Shakiba; Y Shakiba; Tayebeh Pourmotabbed
Journal:  Mol Biol Rep       Date:  2011-06-17       Impact factor: 2.316

3.  Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease.

Authors:  Asad Vaisi-Raygani; Hori Ghaneialvar; Zohreh Rahimi; Haidar Tavilani; Tayebeh Pourmotabbed; Ebrahim Shakiba; Aliakbar Vaisi-Raygani; Amir Kiani; Mahdi Aminian; Reza Alibakhshi; Cynthia Bartels
Journal:  Mol Biol Rep       Date:  2011-04-05       Impact factor: 2.316

4.  Suppression of homocysteine levels by vitamin B12 and folates: age and gender dependency in the Jackson Heart Study.

Authors:  Olivia R Henry; Hamed Benghuzzi; Herman A Taylor; Michelle Tucci; Kenneth Butler; Lynne Jones
Journal:  Am J Med Sci       Date:  2012-08       Impact factor: 2.378

5.  Association between polymorphism of MTHFR c.677C>T and risk of cardiovascular disease in Turkish population: a meta-analysis for 2.780 cases and 3.022 controls.

Authors:  Vildan Bozok Çetintaş; Cumhur Gündüz
Journal:  Mol Biol Rep       Date:  2013-11-22       Impact factor: 2.316

6.  Lack of association between GSTP1 Ile105Val polymorphism and coronary heart disease risk: a meta-analysis.

Authors:  Erjiang Zhao; Yan Zhao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases.

Authors:  Necat Yilmaz
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

Review 8.  Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies.

Authors:  Yazmín Hernández-Díaz; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; Thelma Beatriz González-Castro; Candelario Rodríguez-Pérez; María Lilia López-Narváez; José Manuel Rodríguez-Pérez; José Francisco Cámara-Álvarez
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

9.  Relationship between rs854560 PON1 Gene Polymorphism and Tobacco Smoking with Coronary Artery Disease.

Authors:  Joanna Iwanicka; Tomasz Iwanicki; Paweł Niemiec; Tomasz Nowak; Jolanta Krauze; Władysław Grzeszczak; Sylwia Górczyńska-Kosiorz; Anna Ochalska-Tyka; Iwona Żak
Journal:  Dis Markers       Date:  2017-09-29       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.